Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00881218
Recruitment Status : Completed
First Posted : April 15, 2009
Last Update Posted : April 10, 2012
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Pamela Woodard, MD, Washington University School of Medicine